Incidence and treatment of sexual dysfunction in heart disease;Forekomst og behandling af seksuel dysfunktion ved hjertesygdom

Ugeskrift for Laeger

Volumn 164, Issue 41, 2002, Pages 4760-4764

  Mickley, Hans ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACEBUTOLOL; ANGIOTENSIN RECEPTOR ANTAGONIST; APOMORPHINE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BUCCARD; CALCIUM ANTAGONIST; CARDIOVASCULAR AGENT; CARDOPAX; CARVEDILOL; CLOFIBRATE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DISCOTRINE; GEMFIBROZIL; GLYCERYL TRINITRATE; GLYTRIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; ISODUR; ISOSORBIDE 5 NITRATE; ISOSORBIDE DINITRATE; ISOSORBIDE MONONITRATE; LISINOPRIL; NITRATE; PEM MONO RETARD; PERTIL RETARD; PROPRANOLOL; SILDENAFIL; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; YOHIMBINE;

AGE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG CONTRAINDICATION; DRUG EFFICACY; HEART DISEASE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INCIDENCE; REVIEW; RISK FACTOR; SEXUAL DYSFUNCTION; SMOKING;

ADULT; AGED; CARDIOTONIC AGENTS; CORONARY DISEASE; HUMANS; IMPOTENCE; INCIDENCE; MALE; MIDDLE AGED; PENILE ERECTION; PHOSPHODIESTERASE INHIBITORS; RISK FACTORS; VASODILATOR AGENTS;

EID: 0037037375     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. DeBusk R, Drory Y, Goldstein I, Jackson I, Kaul S, Kimmel SE et al. Management of sexual dysfunction in patients with cardiovascular disease: Recommendations of the Princeton Consensus Panel. Am J Cardiol 2000; 86:175-81.
2. NIH Consus development panel on impotence. Impotence. JAMA 1993; 270: 83-90.
3. Morley JE. Management of impotence. Postgrad Med 1993; 93: 65-72.
4. Furlow W. Prevalence of impotence in the United States. Med Aspects Hum Sex 1985; 19:13-4.
5. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychological correlates; results of the Massachusetts male aging study. J Urol 1994; 151: 54-61.
6. Feldman HA, Johannes CB, Derby CA, Kleinman KP, Mohr BA, Araujo AB et al. Erectile dysfunction and coronary risk factors: Prospective results from the Massachusettes Male Aging Study. Prevent Med 2000; 30: 328-38.
7. Chew KK, Earle CM, Stuckey BGA, Jamrozik K, Keogh E. Erectile dysfunction in general medicine practice: Prevalence and clinical correlates. Int J Impot Res 2000; 12: 41-5.
8. Gundle MJ, Reeves Br Jr, Tate S, Raft D, McLaurin LP. Psychosocial outcome after aortocoronary artery surgery. Am J Psych 1980; 137: 1591-4.
9. Bortolotti A, Parazzini F, Colli E, Landoni M. The epidemiology of erectile dysfunction and its risc factors. Int J Androl 1997; 20: 323-34.
10. Bulpitt C, Dollery C, Carne S. Change in symptoms of hypertensive patients after referral to hospital clinic. Br Heart J 1976; 38: 121-8.
11. Wabrek A, Burchell RC. Male sexual dysfunction associated with coronary heart disease. Arch Sexual Behav 1980; 9: 69-75.
12. Greenstein A, Chen J, Miller H, Matzkin H, Villa Y, Braf Z. Does severity of ischaemic coronary disease correlate with erectile function? Int J Impot Res 1997; 9: 123-6.
13. Rerkpattanapipat P, Stanek MS, Kotler MN. Sex and the heart: What is the role of the cardiologist? Eur Heart J 2001; 22: 201-8.
14. MRC trial of treatment of mild hypertension: Principal results. Medical Research Council Working Party. Br Med J (Clin Reg Ed) 1985; 291: 97-104.
15. Chang SW, Fine R, Siegel D, Chesney M, Black D, Hulley SB. The impact of diuretic therapy on reported sexual function. Arch Intern Med 1991; 151: 2402-8.
16. Grimm RH, Grandits GA, Prineas RJ, McDonald RH, Lewis CE, Flack JM et al. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS). Hypertension 1997; 29: 8-14.
17. Bulpitt CJ, Beevers DG, Butler A, Coles EC, Hunt D, Munro-Faure AD et al. The effects of anti-hypertensive drugs on sexual function in men and women: A report from the DHSS Hypertension Care Computing Project (DHCCP). J Hum Hypertens 1989; 3: 53-6.
18. Prisant LM, Weir MR, Frishman WH, Neutel JM, Davidov ME, Lewin AJ. Self reported sexual dysfunction in men and women treated with bisoprolol, hydrochlorthiazide, enalapril, amlodipine, placebo, or bisoprolol/hydrochlorthiazide. J Clin Hypertens 1999; 1: 22-6.
19. Burchardt M, Burchardt T, Baer L, Kiss AJ, Pawar RV, Shabsigh A et al. Hypertension is associated with severe erectile dysfunction. J Urol 2000; 164: 1188-91.
20. Lue TF. Erectile dysfunction. N Engl J Med 2000; 15: 1802-12.
21. Adverse reactions to bendrofluazide and propanolol for the treatment of mild hypertension. Report of Medical Research Council Working Party on Mild to Moderate Hypertension. Lancet 1981; 2: 539-43.
22. Broekman CP, Haensel SM, Van de Ven LL, Slob AK. Bisoprolol and hypertension: Effects on sexual functioning in men. J Sex Marital Ther 1992; 18: 325-31.
23. Fogari R, Zoppi A, Corradi L, Mugellini A, Poletti L, Lusardi. Sexual function in hypertensive males treated with lisinopril or atenolol: A cross-over study. Am J Hypertens 1998; 11: 1244-7.
24. Fogari R, Zoppi A, Poletti L, Marasi G, Mugellini A, Corradi L Sexual activity in hypertensive men treated with valsartan or carvedilol: A crossover study. Am J Hypertens 2001; 14: 27-31.
25. Gupta S, Salimpour P, Saenz I, Daley J, Gholami S, Daller M et al. A possible mechanism for alteration of human erectile function by digoxin: Inhibition of corpus cavernosum sodium/potassium adenosine triphosphatase activity. J Urol 1998; 159: 1529-36.
26. Wei M, Macera CA, Davis DR, Hornung CA, Nankin HR, Blair SN. Total cholesterol and high density lipoprotein cholesterol as important predictors of erectile dysfunction. Am J Epidol 1994; 140: 930-7.
27. Pedersen TR, Færgemann O. Simvastatin seems unlikely to cause impotence. BMJ 1994; 15: 264-70.
28. Ernst E, Pittler MH. Yohimbine for erectile dysfunction: A systematic review and metaanalysis of randomised clinical trials. J Urol 1998; 159: 433-6.
29. Reid K, Surridge DH, Morales A, Chondra M, Harris C, Owen J et al. Double-blind trial of yohimbine in treatment of psychogenic impotence. Lancet 1987; 2: 421-3.
30. Morales A, Chondra M, Owen JA, Surridge DH, Fenemore J, Harris C. Is yohimbine effective in the treatment of organic impotence? Results of a controlled trial. J Urol 1987; 137: 116.
31. Tam SV, Worcel M, Wyllie M. Yohimbine: A clinical review. Pharmacol Ther 2001; 91: 215-43.
32. Mansoor GA. Herbs and alternative therapies in the hypertension clinic. Am J Hypertens 2001; 14: 971-5.
33. Dula E, Bukofzer S, Renee Perdok, George M, the Apomorphine SL Study Group. Double-blind, crossover comparison of 3 mg apomorphine SL with placebo and with 4 mg apomorphine SL in male erectile dysfunction. Eur Urol 2001; 39: 558-64.
34. Herrmann HC, Chang G, Klugherz BD, Mahoney PD. Hemodynamic effects of sildenafil in men with severer coronary artery disease. N Eng J Med 2000; 342: 1622-6.
35. Arruda-Olson AM, Mahoney DW, Nehra A, Leckel M, Pelikka PA. Cardiovascular effects of sildenafil during exercise in men with known or probable coronary artery disease. JAMA 2002; 287: 719-25.
36. Mickley H, Agner E, Saunamäki, Bøtker HE. Seksuel aktivitet ved iskæmisk hjertesygdom. Risiko og behandlingsmuligheder. Ugeskr Læger 2001; 163: 603-7.
37. Webb DJ, Muirhead GJ, Wulff M, Sutton JA, Levi R, Dinsmore WW. Sildenafil citrate potentiates the hypotensive effects of nitric oxide donor drugs in male patients with stable angina. J Am Coll Cardiol 2000; 36: 25-31.
38. Stief CG, Wetterauer U. Erectile responses to intracavernous papavarine and phentolamine: Comparison of single and combined delivery. J Urol 1988; 140:1415-6.
39. Williams G, Abbou CC, Amar ET, Desvaux P, Flam TA, Lycklama A et al. Efficacy and safety of transurethral alprostadil therapy in men with erectile dysfunction. MUSE Study Group. Br J Urol 1998; 81: 889-94.
40. Padma-Nathan H, Hellstrom WJ, Kaiser FE, Labasky RF, Lue TF, Nolten WE, et al. Treatment of men with erectile dysfunction with transurethral alprostadil. MUSE Study Group. N Engl J Med 1997; 334: 1-7.